Ondine Biopharma Corporation, a biotechnology company, engages in the development and commercialization of anti-infective therapies for the treatment of bacterial, fungal, and viral infections primarily using Photodisinfection technology in Canada. Its Photodisinfection technology utilizes photoactive agents and light sources to effect disinfection across various applications. The company primarily offers Periowave for the treatment of periodontal disease, an infection of the gums. Ondine Biopharma Corporation is headquartered in Vancouver, Canada.